Status:
COMPLETED
Pharmacist Discharge Medication Reconciliation Study
Lead Sponsor:
Alberta Health services
Conditions:
Medication Reconciliation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing...
Eligibility Criteria
Inclusion
- Cancer inpatients under the care of Dr. Follett or Dr. Candler
- Cancer inpatients to be discharged from the CCI
- Patients \>18 years of age
- Patients that are taking \>1 medications or herbals total at home.
Exclusion
- Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
- Patients that do not remain in hospital \>72 hours
- Patients without a home phone number or equivalent contact number.
- Language barrier (patients unable to speak or understand English).
- Patients that are readmitted and already included into the study.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01226589
Start Date
October 1 2007
End Date
October 1 2008
Last Update
April 19 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2